Top 10 Major Companies in the Philippines Scleroderma Market | Insights & Key Players 2026

Q: Which global players are addressing Scleroderma-associated Interstitial Lung Disease in the Philippines?

Boehringer Ingelheim and Roche are at the forefront, offering specialized antifibrotic and biological therapies that help slow the decline of lung function.

Q: Which company leads the antifibrotic segment in the Philippines Scleroderma market?

The market is led by Boehringer Ingelheim, owing to its extensive reach and the specialized approval of its antifibrotic medication for systemic sclerosis.

Q: Are there any major providers for managing Raynaud’s phenomenon within the scleroderma market?

Companies like Pfizer and Bayer provide essential vasodilators and calcium channel blockers that are crucial for managing the vascular symptoms associated with scleroderma.

Q: How does 6W market outlook report help businesses in making decisions?

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.

Q: Do you also provide customisation in the market study?

Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

Code: MTA12199

Publication Date: Apr 2026

Top 10 Major Companies in the Philippines Scleroderma Market

The Philippines Scleroderma Market is driven by leading companies, each holding a significant portion of the market share through advanced therapeutic drugs and clinical research for systemic sclerosis management. Key players in the market include Boehringer Ingelheim Philippines, Roche Philippines, and Pfizer Philippines.

For detailed forecasts, data tables, and competitive benchmarking,
Explore the full Philippines Scleroderma Market.

View Main Report Schedule Analyst Call

Philippines Scleroderma Market Overview

According to 6Wresearch, the Philippines scleroderma market is growing rapidly due to the rising prevalence of autoimmune disorders and the rising adoption of biological therapies. Scleroderma is recognized by the hardening of the skin and potential damage to internal organs such as the lungs and heart.

The growing occurrence of Interstitial Lung Disease associated with scleroderma has led to an increasing demand for antifibrotic treatments. The increased investment in biotechnology and the development of biosimilars are further contributing to the growth of the market.

Competitive Landscape

The competitive landscape of the Philippines Scleroderma Industry includes global pharmaceutical giants and innovative domestic biotech firms, offering the latest technology therapeutic tools required for the management of the disease. The key players are actively engaged in the development and supply of immunosuppressants, antifibrotics, and vasodilators.

Below is a list of leading players operating in the Philippines Scleroderma Market:

1. Boehringer Ingelheim Philippines

Company Name	Boehringer Ingelheim Philippines
Established Year	1885 (Global) / 1966 (PH)
Headquarters	Ingelheim, Germany (Global) / Makati City, Philippines
Official Website	-

Boehringer Ingelheim is a dominant leader in the scleroderma space, providing Ofev, which is essential for treating scleroderma-associated interstitial lung disease.

2. Roche Philippines

Company Name	Roche Philippines
Established Year	1896 (Global) / 1962 (PH)
Headquarters	Basel, Switzerland (Global) / Makati City, Philippines
Official Website	Click Here

Roche maintains a strong presence with its Actemra portfolio, focusing on reducing lung function for patients with systemic sclerosis.

3. Pfizer Philippines

Company Name	Pfizer Philippines
Established Year	1849 (Global) / 1954 (PH)
Headquarters	New York City, New York, United States (Global) / Makati City, Philippines
Official Website	Click Here

Pfizer provides established anti-inflammatory and immunosuppressive medications that support the overall management of systemic sclerosis complications.

4. Novartis Philippines

Company Name	Novartis Philippines
Established Year	1996
Headquarters	Basel, Switzerland (Global) / Makati City, Philippines
Official Website	Click Here

Novartis offers specialized treatments and various immunosuppressants, targeting underlying pathways that cause skin thickening and organ involvement.

5. AstraZeneca Philippines

Company Name	AstraZeneca Philippines
Established Year	1999
Headquarters	Cambridge, United Kingdom (Global) / Taguig City, Philippines
Official Website	-

AstraZeneca is a key contributor through its research into biological therapies and medications that manage vascular complications related to scleroderma.

6. GlaxoSmithKline (GSK) Philippines

Company Name	GlaxoSmithKline (GSK) Philippines
Established Year	2000
Headquarters	Brentford, United Kingdom (Global) / Makati City, Philippines
Official Website	-

GSK contributes to the market with a portfolio of treatments for pulmonary arterial hypertension, a common and serious complication of systemic sclerosis.

7. Sanofi Philippines

Company Name	Sanofi Philippines
Established Year	1973 (Global) / 2004 (Sanofi-Aventis PH)
Headquarters	Paris, France (Global) / Taguig City, Philippines
Official Website	-

Sanofi offers various treatments for secondary Raynaud's phenomenon and skin symptoms, supporting the quality of life for scleroderma patients.

8. Johnson & Johnson Philippines

Company Name	Johnson & Johnson Philippines
Established Year	1886 (Global) / 1956 (PH)
Headquarters	New Brunswick, New Jersey, United States (Global) / Parañaque City, Philippines
Official Website	-

Johnson & Johnson is active in the market through its Janssen pharmaceutical division, focusing on therapies for autoimmune and pulmonary complications.

9. Bayer Philippines

Company Name	Bayer Philippines
Established Year	1863 (Global) / 1962 (PH)
Headquarters	Leverkusen, Germany (Global) / Taguig City, Philippines
Official Website	-

Bayer provides vasodilator therapies and medications aimed at managing the vascular and hypertensive aspects of systemic sclerosis.

10. Eli Lilly Philippines

Company Name	Eli Lilly Philippines
Established Year	1876 (Global) / 1960s (PH)
Headquarters	Indianapolis, Indiana, United States (Global) / Taguig City, Philippines
Official Website	Click Here

Eli Lilly provides advanced treatments for inflammatory conditions and research-based solutions for autoimmune diseases that overlap with scleroderma.